Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 152(1): 47-9, 2011 Nov.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-22803037

RESUMO

We studied changes in the levels of inhibitory and excitatory neurotransmitters in female rat brain structures during different phases of the estrous cycle in health and after creation of a cobalt epileptogenic focus at stage I of epileptogenic system development. The most pronounced shifts were found in the contralateral cortex, where the levels of GABA and glycine decreased significantly during the diestrus-2 phase (corresponding to menstruation), which attests to a convulsive threshold decrease during this period.


Assuntos
Ácido Aspártico/metabolismo , Epilepsia/metabolismo , Ciclo Estral/metabolismo , Glicina/metabolismo , Hipocampo/metabolismo , Hipotálamo/metabolismo , Ácido gama-Aminobutírico/metabolismo , Animais , Animais não Endogâmicos , Cobalto , Epilepsia/induzido quimicamente , Aminoácidos Excitatórios/metabolismo , Feminino , Córtex Motor/metabolismo , Córtex Motor/patologia , Ratos , Taurina/metabolismo
2.
Eksp Klin Farmakol ; 62(4): 3-6, 1999.
Artigo em Russo | MEDLINE | ID: mdl-10513325

RESUMO

The activity of the new original compound--hydrochloride N-2-(adamantyl) hexamethylenimine (code A-7) synthesized at the Institute of Pharmacology, Russian Academy of Medical Sciences, was studied on models of akinetic-rigid and tremor manifestations of the parkinsonian syndrome. A-7 completely relieves the akinetic-rigid manifestations of the syndrome and surpasses mydantan and L-dopa in antagonism with haloperidol and triftazine. Just as L-dopa, cyclodol, and mydantan, A-7 alleviates reserpine-induced oligokinesis and restores body temperature which is lowered by reserpine. A-7 possesses evident antitremor activity which advantageously distinguishes it from mydantan which failed to demonstrate antagonism with arecoline. A-7 is promising for further study as a potential agent for the treatment of parkinsonism.


Assuntos
Adamantano/análogos & derivados , Antiparkinsonianos/uso terapêutico , Adamantano/uso terapêutico , Amantadina/uso terapêutico , Animais , Doenças dos Gânglios da Base/induzido quimicamente , Doenças dos Gânglios da Base/tratamento farmacológico , Catalepsia/induzido quimicamente , Catalepsia/tratamento farmacológico , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Interações Medicamentosas , Levodopa/uso terapêutico , Masculino , Camundongos , Transtornos Parkinsonianos/induzido quimicamente , Transtornos Parkinsonianos/tratamento farmacológico , Ratos , Triexifenidil/uso terapêutico
3.
Eksp Klin Farmakol ; 56(6): 8-11, 1993.
Artigo em Russo | MEDLINE | ID: mdl-8111305

RESUMO

Two-hour hypobaric hypoxia of rats on day 15 of their pregnancy led to a reduction in weight gain of pups within 20 days after birth, disturbed memory in active and passive paradigms, changed adaptive behavior in the extrapolatory water avoidance test, and impaired sleep in adult animals. Postnatal treatment with sodium hydroxybutyrate given in a dose of 50 mg/kg/day on days 8 to 20 of life normalized mnestic functions of the brain, the process of falling asleep, and physical development which had been impaired by intrauterine hypoxia.


Assuntos
Sistema Nervoso Central/efeitos dos fármacos , Hipóxia Fetal/tratamento farmacológico , Efeitos Tardios da Exposição Pré-Natal , Oxibato de Sódio/farmacologia , Animais , Câmaras de Exposição Atmosférica , Sistema Nervoso Central/fisiopatologia , Condicionamento Clássico/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Reação de Fuga/efeitos dos fármacos , Feminino , Hipóxia Fetal/fisiopatologia , Masculino , Memória/efeitos dos fármacos , Gravidez , Ratos , Tempo de Reação/efeitos dos fármacos , Oxibato de Sódio/uso terapêutico , Fatores de Tempo
4.
Biull Eksp Biol Med ; 114(9): 286-8, 1992 Sep.
Artigo em Russo | MEDLINE | ID: mdl-1477361

RESUMO

The pineal hormone melatonin in a dose-effect manner (0.1, 1 and 10 mg/kg) reorganized EEG spectral characteristics of rat sensorimotor cortex and hippocampus, decreasing medium (6-12 Hz) and high frequency (12-22 Hz) waves only in the evening. On the contrary, pinealectomy increased high-frequency waves only during morning hours. It is suggested that the observed changes may accompany anxiolytic and hypnotic effects of melatonin.


Assuntos
Encéfalo/fisiologia , Ritmo Circadiano , Melatonina/farmacologia , Glândula Pineal/cirurgia , Animais , Eletroencefalografia , Hipocampo/fisiologia , Masculino , Córtex Motor/fisiologia , Ratos , Córtex Somatossensorial/fisiologia
5.
Farmakol Toksikol ; 53(1): 20-2, 1990.
Artigo em Russo | MEDLINE | ID: mdl-2109704

RESUMO

In experiments on albino male rats with chronically implanted electrodes and an epileptogenic focus in the cortical sensomotor region it was shown that a derivative of 3-hydroxy-pyridine (2-ethyl-6-methyl-3-hydroxypyridine) possesses the pronounced antiepileptic effect. The effect of the agent is related to the functional state of the epileptic system whose resistance to pharmacotherapy depends on the power of the determinant focus.


Assuntos
Antioxidantes/uso terapêutico , Epilepsias Parciais/tratamento farmacológico , Picolinas/uso terapêutico , Animais , Doença Crônica , Cobalto , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Epilepsias Parciais/induzido quimicamente , Epilepsias Parciais/fisiopatologia , Masculino , Córtex Motor/efeitos dos fármacos , Córtex Motor/fisiopatologia , Ratos , Fatores de Tempo
6.
Biull Eksp Biol Med ; 108(12): 697-700, 1989 Dec.
Artigo em Russo | MEDLINE | ID: mdl-2634443

RESUMO

During experiments conducted on albino rats the deficiency of passive avoidance retention was shown to correlate not only with the reduction in REM sleep and SWS, but also with disappearance of phasic component of theta-rhythm. Drugs with nootropic mode of action (cleregyl, centrophenoxin, antioxidant 3-xypyridine) recovered the deficiency of passive avoidance retention and increased phasic component of theta-Rhythm, while phenazepam enhanced tonic component of theta-rhythm, and failed to act upon learning deficits. It seems likely from these results that the electrophysiological correlates of antiamnestic effect is the maintenance of proper two-component theta-rhythm and the increase in its phasic component, whereas the destructuring of sleep, including REM sleep reduction is not considered to be key determinant in the action upon memory and learning procedure.


Assuntos
Amnésia/tratamento farmacológico , Eletroencefalografia/efeitos dos fármacos , Psicotrópicos/uso terapêutico , Privação do Sono/fisiologia , Sono REM/fisiologia , Amnésia/fisiopatologia , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Aprendizagem da Esquiva/fisiologia , Condicionamento Clássico/efeitos dos fármacos , Condicionamento Clássico/fisiologia , Avaliação Pré-Clínica de Medicamentos , Eletrodos Implantados , Masculino , Ratos , Sono REM/efeitos dos fármacos
8.
Biull Eksp Biol Med ; 95(4): 50-3, 1983 Apr.
Artigo em Russo | MEDLINE | ID: mdl-6403074

RESUMO

The central neurotropic effects of 4-phenylpyracetam, a new phenyl analog of pyracetam, were studied and compared with the effects of pyracetam, morpholene and 4-phenylpyrrolidone. 4-Phenylpyracetam was found to activate the operant behavior more powerfully, to remove psychodepressant effects of diazepam, to inhibit post-rotational nystagmus, and to prevent the development of retrograde amnesia. Unlike pyracetam, 4-phenylpyracetam exhibits a specific anticonvulsant action. When given in high doses, the compound under study produces psychodepressant effects.


Assuntos
Piracetam/farmacologia , Pirrolidinonas/farmacologia , Animais , Anticonvulsivantes/farmacologia , Condicionamento Operante/efeitos dos fármacos , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Epilepsias Parciais/tratamento farmacológico , Cobaias , Camundongos , Morfolinas/farmacologia , Nistagmo Fisiológico/efeitos dos fármacos , Piracetam/análogos & derivados , Piracetam/uso terapêutico , Piracetam/toxicidade , Ratos
10.
Farmakol Toksikol ; 43(5): 546-51, 1980.
Artigo em Russo | MEDLINE | ID: mdl-6108867

RESUMO

Studies of the new benzodiazepine drug phenazepam comparatively to diazepam, clonazepam, nitrazepam, phenobarbital and diphenylhydantoin have shown that by its anticonvulsant effects phenazepam is similar to clonazepam and differs from other antiepileptic agents. Phenazepam exhibits a pronounced capacity for removing paroxysmal epileptiform discharges induced by cobalt application to the surface of the brain cortex. Prolonged administration induces tolerance to phenazepam as shown by antagonism to strychnine and by capacity for preventing convulsions in maximal electric shock.


Assuntos
Ansiolíticos/uso terapêutico , Anticonvulsivantes , Benzodiazepinas , Benzodiazepinonas/uso terapêutico , Convulsões/tratamento farmacológico , Animais , Avaliação Pré-Clínica de Medicamentos , Tolerância a Medicamentos , Eletroencefalografia , Masculino , Camundongos , Ratos , Convulsões/induzido quimicamente , Convulsões/fisiopatologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA